330 related articles for article (PubMed ID: 16574537)
1. Sildenafil as adjunct therapy to high-dose epoprostenol in a patient with pulmonary veno-occlusive disease.
Kuroda T; Hirota H; Masaki M; Sugiyama S; Oshima Y; Terai K; Ito A; Yamauchi-Takihara K
Heart Lung Circ; 2006 Apr; 15(2):139-42. PubMed ID: 16574537
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary veno-occlusive disease presenting with recurrent pulmonary oedema and the use of nitric oxide to predict response to sildenafil.
Creagh-Brown BC; Nicholson AG; Showkathali R; Gibbs JS; Howard LS
Thorax; 2008 Oct; 63(10):933-4. PubMed ID: 18820120
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil for pulmonary hypertension.
Lee AJ; Chiao TB; Tsang MP
Ann Pharmacother; 2005 May; 39(5):869-84. PubMed ID: 15827074
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
[TBL] [Abstract][Full Text] [Related]
5. Oral sildenafil reduces pulmonary hypertension after cardiac surgery.
Trachte AL; Lobato EB; Urdaneta F; Hess PJ; Klodell CT; Martin TD; Staples ED; Beaver TM
Ann Thorac Surg; 2005 Jan; 79(1):194-7; discussion 194-7. PubMed ID: 15620942
[TBL] [Abstract][Full Text] [Related]
6. Veno-venous extracorporeal membrane oxygenation bridging to pharmacotherapy in pulmonary arterial hypertensive crisis.
Srivastava MC; Ramani GV; Garcia JP; Griffith BP; Uber PA; Park MH
J Heart Lung Transplant; 2010 Jul; 29(7):811-3. PubMed ID: 20417127
[TBL] [Abstract][Full Text] [Related]
7. Sildenafil in the management of primary pulmonary hypertension.
Singh B; Gupta R; Punj V; Ghose T; Sapra R; Grover DN; Kaul U
Indian Heart J; 2002; 54(3):297-300. PubMed ID: 12216929
[TBL] [Abstract][Full Text] [Related]
8. Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease.
Montani D; Jaïs X; Price LC; Achouh L; Degano B; Mercier O; Mussot S; Fadel E; Dartevelle P; Sitbon O; Simonneau G; Humbert M
Eur Respir J; 2009 Dec; 34(6):1348-56. PubMed ID: 19541723
[TBL] [Abstract][Full Text] [Related]
9. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
[TBL] [Abstract][Full Text] [Related]
10. A case of pulmonary veno-occlusive disease: diagnostic dilemmas and therapeutic challenges.
Sourla E; Paspala A; Boutou A; Kontou P; Stanopoulos I; Pitsiou G
Ther Adv Respir Dis; 2013 Apr; 7(2):119-23. PubMed ID: 23235992
[TBL] [Abstract][Full Text] [Related]
11. [Aerosolized iloprost combined with a phosphodiesterase inhibitor in the treatment of primary pulmonary hypertension].
Isa R; Castro P; Martínez A
Rev Med Chil; 2004 Mar; 132(3):353-6. PubMed ID: 15376573
[TBL] [Abstract][Full Text] [Related]
12. PPHN: is sildenafil the new nitric? A review of the literature.
Spillers J
Adv Neonatal Care; 2010 Apr; 10(2):69-74. PubMed ID: 20386371
[TBL] [Abstract][Full Text] [Related]
13. Bosentan and sildenafil: should the combination therapy be a valid alternative in childhood to prostacyclin infusion?
Brancaccio G; Toscano A; Bevilacqua M; Di Chiara L; Parisi F
Pediatr Transplant; 2007 Feb; 11(1):110-2. PubMed ID: 17239133
[TBL] [Abstract][Full Text] [Related]
14. [Pulmonary hypertension in left heart disease].
Opitz CF; Gläser S; Ewert R
Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S167-9. PubMed ID: 19718607
[TBL] [Abstract][Full Text] [Related]
15. Non erectile dysfunction application of sildenafil.
Cremers B; Böhm M
Herz; 2003 Jun; 28(4):325-33. PubMed ID: 12825148
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary arterial hypertension in the pediatric age.
Donti A; Formigari R; Ragni L; Manes A; Galiè N; Picchio FM
J Cardiovasc Med (Hagerstown); 2007 Jan; 8(1):72-7. PubMed ID: 17255821
[TBL] [Abstract][Full Text] [Related]
17. Scheduled perioperative switch from oral sildenafil to intravenous epoprostenol in a patient with Eisenmenger syndrome undergoing a sigmoidectomy.
Moriyama K; Uzawa K; Iijima T; Kotani M; Moriyama K; Ohashi Y; Satoh T; Yorozu T
J Clin Anesth; 2012 Sep; 24(6):487-9. PubMed ID: 22762976
[TBL] [Abstract][Full Text] [Related]
18. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial.
Ghofrani HA; Wiedemann R; Rose F; Schermuly RT; Olschewski H; Weissmann N; Gunther A; Walmrath D; Seeger W; Grimminger F
Lancet; 2002 Sep; 360(9337):895-900. PubMed ID: 12354470
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil treatment of primary pulmonary hypertension.
Laupland KB; Helmersen D; Zygun DA; Viner SM
Can Respir J; 2003; 10(1):48-50. PubMed ID: 12624621
[TBL] [Abstract][Full Text] [Related]
20. Favorable outcome of pregnancy with an elective use of epoprostenol and sildenafil in women with severe pulmonary hypertension.
Goland S; Tsai F; Habib M; Janmohamed M; Goodwin TM; Elkayam U
Cardiology; 2010; 115(3):205-8. PubMed ID: 20173324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
